|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.60 EUR | -1.29% |
|
+4.76% | +35.30% |
| 23/06 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors |  |
| 12/06 | Could This Finally Be the One? | |
| Market Cap | 1.33TCr 1.52TCr 1.23TCr 1.15TCr 2.16TCr 1,43400Cr 2.2TCr 15TCr 5.72TCr 71TCr 5.71TCr 5.59TCr 2,45800Cr | P/E 2026 * |
15x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2TCr 1.37TCr 1.1TCr 1.03TCr 1.94TCr 1,28800Cr 1.98TCr 13TCr 5.13TCr 64TCr 5.13TCr 5.01TCr 2,20700Cr | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.45x |
| Free-Float |
40.65% | Yield 2026 * |
0.88% | Yield 2027 * | 0.91% |
Last Transcript: Ipsen
| 1 day | -1.29% | ||
| 1 week | +4.76% | ||
| Current month | +3.48% | ||
| 1 month | -0.56% | ||
| 3 months | +7.14% | ||
| 6 months | +34.84% | ||
| Current year | +35.30% |
| 1 week | 155.5 |  | 162.7 |
| 1 month | 150.6 | | 162.7 |
| Current year | 116.5 | | 172.7 |
| 1 year | 101.3 | | 172.7 |
| 3 years | 90.2 | | 172.7 |
| 5 years | 77.76 | | 172.7 |
| 10 years | 36.84 | | 172.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 01/07/2020 |
| Chief Executive Officer | 57 | 01/01/2020 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 30/08/2005 |
| Chairman | 68 | 22/11/2010 | |
Carol Xueref
BRD | Director/Board Member | 69 | 01/06/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | +4.76% | - | - | 1.52TCr | |
| +7.13% | +9.97% | +51.94% | +166.83% | 1,00600Cr | |
| +3.99% | +11.50% | +67.53% | +55.63% | 59TCr | |
| +4.20% | +17.03% | +35.63% | +87.74% | 43TCr | |
| +0.99% | +4.85% | +27.93% | +22.82% | 33TCr | |
| +1.82% | +8.19% | +41.15% | +26.80% | 29TCr | |
| +0.22% | +6.75% | +31.51% | +42.02% | 28TCr | |
| +0.73% | +8.53% | -26.22% | -40.85% | 21TCr | |
| +1.56% | +6.14% | +28.38% | +59.45% | 19TCr | |
| +3.26% | +3.33% | +18.83% | +67.03% | 15TCr | |
| Average | +1.73% | +8.46% | +30.74% | +54.16% | 38.73TCr | |
| Weighted average by Cap. | +2.24% | +9.14% | +40.20% | +79.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 425.35Cr 485.12Cr 392.08Cr 367.07Cr 688.31Cr 46TCr 702.6Cr 4.71TCr 1.82TCr 23TCr 1.82TCr 1.78TCr 78TCr | 446.93Cr 509.73Cr 411.97Cr 385.69Cr 723.23Cr 48TCr 738.25Cr 4.95TCr 1.92TCr 24TCr 1.91TCr 1.87TCr 82TCr |
| Net income | 92Cr 105.28Cr 85Cr 80Cr 149.37Cr 9.93TCr 152.47Cr 1.02TCr 395.71Cr 4.91TCr 395.31Cr 386.68Cr 17TCr | 94Cr 106.96Cr 86Cr 81Cr 151.75Cr 10TCr 154.9Cr 1.04TCr 402.02Cr 4.99TCr 401.62Cr 392.85Cr 17TCr |
| Net Debt | -136.19Cr -155.33Cr -125.54Cr -117.53Cr -220.39Cr -15TCr -224.96Cr -1.51TCr -583.85Cr -7.24TCr -583.26Cr -570.52Cr -25TCr | -237.18Cr -270.5Cr -218.62Cr -204.68Cr -383.8Cr -26TCr -391.77Cr -2.63TCr -1.02TCr -13TCr -1.02TCr -993.56Cr -44TCr |
| Date | Price | Change |
|---|---|---|
| 26/26/26 | €160.60 | -1.29% |
| 25/26/25 | €162.70 | +0.31% |
| 24/26/24 | €162.20 | +4.31% |
| 23/26/23 | €155.50 | -0.06% |
| 22/26/22 | €155.60 | +1.50% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
Select your edition
All financial news and data tailored to specific country editions
